Genekam making ready
for Nasdaq IPO 2024
Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
A number of Genekam products are registered with EUDAMED
A step towards meeting the lastest IVDR requirements
Genekam is to attend LSX World conference 29-30 April, 2024, Business Design Center, London, UK
Visit us on Medica Duesseldorf, 11.-14. November 2024
Genekam is developing ultrasensitive magnetic beads ELISA, which can be used as point of care. Moreover it will finish within 40 minutes and 10000 times sensitive than conventional ELISA, which need almost a day to be completed and has less sensitive as magnetic beads provide 3D structure for antigen and antibody interaction, hence the results are far better and the results can be see through the naked eyes and read with ELISA reader, if user needs to record the values of absorbance. The test is ready to use and it can be done through any technical person in laboratory and clinics.
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
Genekam has developed detection kits and potential therapeutic molecules for Nipah virus
Genekam developed potential therapeutic human anitbodies against Chlamydia
Genekam has developed a number of new breast cancer tumor markers from blood samples
Genekam products can be paid in Bitcoin. (basis of conversion rate from bitcoin-exchange)
Genekam has developed human antibodies (true antibodies, therapeutic antibodies) against H5N1 and now we are working to generate sufficient quantity to conduct other assays!
Genekam has formed a new company called
3D Genome Medicine Inc. in order to start operations in USA. Shortly website and adress!
Genekam Biotechnology AG is going to add UDI code (Unique Device Identification) to its CE marked kits shortly
Genekam is going to open a new company in USA (most likely near Washington DC) to develop, manufacture and distribute its products. Please follow us on our website! Thanks to local Govt and other agencies for excellent support!
Genekam Biotechnology AG is a registered supplier of a number of german medical universities and its institutes from last a few weeks. If users of these institutes need the supplier number while ordering, let us know!
Mr. Garrelt Duin, Minister of economic Affairs of our state Northrhine-Westphalia, visited our booth on 14.11.2016 at Medica and asked about innovative solutions for viruses and stemcells.
Genekam has developed a test for detection of H5N6 influenza virus, which is outbreaking in many countries now.
Studies are showing Genekam potential therapeutic molecules are working against Zika virus.
Zika Virus-Single Check FR325 is now with CE-IVD.
New kit -Yellow Fever, Zika Virus and Chikungunya Virus FR351- is available now
New 4:1 kit Zika virus, Dengue virus (1-4) and Chikungunya virus FR342 (realtime PCR kit) is available now.
In 2005 during the outbreak H5N1: One of our distributors in Europe said: Minister came and thanks for saving the Govt from big disaster. (Genekam Kit had shown that it is not H5N1 outbreak. The result was later confirmed through two reference laboratories. This country used Fluhuntter: H5 PCR Kit)
In 2014 : One of distributors in Middle East told us that one of highest member of rulers of the country thanks him for supporting to combat against Middle East Syndrome Virus (MERS).
In 2015: One Team in a German medical university in Germany told us that they got excellent curves as well as results with Genekam Rabies realtime kit and other kits. They tried other kits from bigg...
GenekamReport is a medical App to document and store the results of PCR (polymerase chain reactions) experiments in your mobile Phone or tablet PC. Further information
FR024 Humanes Herpes Simplex Virus 1 & 2 -Multiplex (Ready to use Realtime PCR-Kit)
FR013A Mycobacterium tuberculosis – Double Check (Ready to use RealTime PCR-Kit)
FR060 Fluhunter Influenza A Virus (Ready to use realtime PCR kit) CE
FR004 Bordetella pertussis (Ready to use realtime PCR kit) CE
Das Markieren von Wertgegenständen mit künstlicher DNA als Präventionsstrategie hat sich als äußerst wirksam erwiesen. Der Einsatz solcher Produkte ermöglicht es, mit künstlicher DNA markierte Gegenstände zuverlässig ihrem Eigentümer zuzuordnen und lässt oft den Täter mit dem Tatort verbinden. Genekam Biotechnology AG ist als Hightech-Unternehmen mit Sitz in Duisburg auf DNA-Technologien spezialisiert. Wir entwickeln und vertreiben DNA-basierte Lösungen (Made In Germany). Genekam bietet auf neuester DNA-Technologie basierte Lösungen zur Prävention in den Bereichen Diebstahl und Eigentumsnachweis an. Die DNA-Technologien bieten vielfältige Möglichkeiten im Sicherheitsbereich,...
Two more products (Ready to use PCR kit for Leptospira, kit number K017A and DNA positive control for Leptospira, kit number D0007) are available with CE.
Genekam has developed new Realtime PCR kits for Influenzaviruses of types H4, H6, H8 and H7N9.
Genekam has developed a number of therapeutic molecules for therapy of Ebola virus, Middle east Syndrome virus and Influenza virus (H1N1)
Genekam Biotechnology AG has launched a new company called MICROBOSS Hightech to serve the market of plant pathology and environmental issues.
Genekam Biotechnology AG is a registered supplier of Food and Agricultural Organisation (FAO) and thanks for sourcing kits to combat outbreaks.
1. Fluhunter: MERS and Influenza A virus (FR 206)
2. Fluhunter: MERS, Influenza A virus + Respiratory synctial virus
3. Fluhunter: MERS double check (FR208)
ZDF-German-TV under Frontal21 has shown a film about Corruption in WHO (World Health Organisation) under WHO-Korruption on 21.10.2014. Please watch it here.
Genekam Biotechnology AG has started developing different magnetic beads applications for cellculture, RNA / DNA isolation, protein isolations, transfection etc.
Genekam Completed successfully one project under the Program ZIM from Federal Ministry for Economic Affairs and Energy
Genekam has developed a number of ready to use PCR kits to detect different kinds of corona viruses including SARS virus. The outbreaks of the Middle East SARS virus in Qatar, Saudi Arabia, UAE, Egypt etc need an urgent attention to find out the mode of transmission, source of transmission and other scientific issues.
1 More PCR kit with CE: FR 015 Epstein-Barr-Virus (Realtime PCR kit). Total number of kits with CE are 22 now.
2 More PCR kits with CE: FR 077 Human Swine flu H1N1 (Realtime PCR kit) and FR 799 Identification of a human ß-Actin (Realtime PCR kit). Total number of kits with CE are 21 now.
2 More PCR kits with CE: Realtime PCR kits
FR 001 Leptospira and FR 118 Human Internal Control (Total number of kits with CE are 19 now).
We are going to launch a number of new products for stem cells particularly MSC.
Genekam has developed H7N9 PCR kit for detection of recently outbroken avian influenza virus.
Start of EU-Project Fibrogelnet under Marie-Curie-IAPP on 7.03.2013.
Genekam Biotechnology AG has developed conventional PCR kit for Novel Corona virus (London 2012 strain). This is strain, which has outbroken in Middle east: Qatar and Saudi Arabia.
2 More kits with CE: Ureaplasma urealyticum ready to use PCR kit and cDNA positive control for Influenza H5 (total number of kits with CE are 17 now).
4 More kits with CE: Brucella abortus, Mycoplasma genitalium, Mycoplasma pneumoniae and Borrelia burgdorferi positive control (total number of kits with CE are 15 now).
Genekam is to take part in one more project called Fibrogelnet under FP7-PEOPLE-2012-2012 from EU to work on network for development of nanosolutions for nanomedicine. The overall scoring of this project was excellent during evaluation.
Genekam got one project for development of Nanotools for nanomedicine under program ZIM from German Federal Ministry of Economics and Technology.
Genekam is to take part in European Community FP7 funded and approved research project called STRUCTGEL to develop nanomedicine applications in Stemcell field.